ciba-geigy ltd. and chiron corp. said 0 they extended their offer for connaught biosciences inc. , valued at 866 million canadian dollars -lrb- us$ 736 million -rrb- to oct. 27 . the companies earlier said 0 they did n't want to raise their offer to match a rival bid by institut merieux s.a. of c$ 37 a share , or c$ 942 million . but they said 0 the c$ 30-a-share bid , which was due to expire monday , may still be extended or varied . merieux , a vaccine manufacturer based in lyon , france , is 51%-held by french state-owned rhone-poulenc s.a . ciba-geigy is a major pharmaceutical concern based in basel , switzerland . chiron , another pharmaceutical concern , is based in emeryville , calif . connaught is a biotechnology research and vaccine manufacturing concern . institut merieux 's bid for toronto-based connaught has run into problems with the canadian government , which told merieux last week that it was n't convinced that the proposed acquisition would be of `` net benefit '' to canada . merieux officials are expected to meet with federal officials in ottawa today to discuss the decision .